Biotech Startups

Micro Meat develops technological solutions to increase production capacity for cultivated meat manufacturing.

1 investor

Microbiome Insights provides microbiome analysis and testing services using advanced bioinformatics for research applications in academia, pharmaceuticals, consumer goods, and environmental sectors. The company operates as part of Mapmygenome and offers comprehensive multi-omics analysis with end-to-end services.

1 investor

MagIC is a microbiome research center that investigates the relationship between the human gut microbiome and various health conditions to develop diagnostics and therapeutics. The organization serves healthcare professionals, researchers, and industry partners across Hong Kong and beyond.

1 investor

1 investor

MicroIN is a platform that combines cell protection, microencapsulation, and bioinformatics to make sensitive biological inputs (live microorganisms and other bioinputs) more resilient, stable, and scalable. It targets the agro-environmental sector, aiming to improve the shelf life, formulation, and adoption of biology-based agricultural inputs.

1 investor

MicroLub is a UK-based deep-tech ingredient company that develops protein-based biolubricant molecules — protein microgels coated with polysaccharides — that reduce molecular friction to replace fats and oils in food and personal care products while retaining their mouthfeel and texture. It sells bespoke formulation solutions to R&D teams at food manufacturers, ingredient companies, and personal care brands.

1 investor

1 investor

KitoTech Medical develops microMend, a wound closure product combining microstaples with adhesive backing as an alternative to traditional sutures and staples. The company serves both clinical markets through healthcare networks and hospitals, and consumer markets through retail pharmacy chains and online platforms.

1 investor

Microphyt develops microalgae-based ingredients and products for nutrition, dietary supplements, and personal care using proprietary bio-reactor technology. The company serves food, supplement, and cosmetics manufacturers with natural, science-backed ingredients derived from microalgae.

1 investor

Microplate Dx is a diagnostics company developing rapid antimicrobial susceptibility testing technology to identify the correct antibiotic treatment for infections within hours, enabling faster patient treatment and reducing antibiotic resistance. The company targets healthcare providers and focuses on improving clinical outcomes in infectious disease management.

1 investor

Micropoint Technologies is an ISO 13485 certified, cGMP compliant medical device company that develops and manufactures microneedle solutions, including stainless steel, plastic, polymeric, hollow, solid, and custom microneedles. It offers rapid prototyping, product development, and OEM manufacturing, and operates a pilot facility producing clinical batches of dissolving microneedle patches for clinical trials.

1 investor

Micropoint Bio is a microfluidics technology company that develops point-of-care testing (POCT) devices and biochips for clinical diagnostics, including coagulation, cardiac, and infectious disease testing. The company manufactures microfluidic chips and detection instruments for hospitals, laboratories, and clinical settings globally.

1 investor

1 investor

Midwest Bioprocessing Center produces biobased ingredients and compounds from sustainable feedstocks for human health, nutrition, and personal care applications. The company operates through three branded platforms: iActive for cosmetics, zuCarb for pharmaceutical R&D, and bioprocess services.

1 investor

Mighty Therapeutics is a biopharmaceutical company developing mitochondria-targeted medicines to treat mitochondrial dysfunction in rare genetic mitochondrial diseases and common age-related conditions. Its pipeline spans rare genetic diseases, ophthalmic disorders, and neurological conditions, and it delivered the first approved therapy for Barth syndrome.

1 investor

Miist develops inhaled microparticle therapies designed to deliver systemic medication to the bloodstream within about 30 seconds, targeting conditions such as migraine, pain, and nausea. Its lead product, MST-02, is a migraine inhaler being advanced into a Phase 1/2 clinical trial.

1 investor

Mikart is a contract development and manufacturing organization (CDMO) that provides pharmaceutical development and manufacturing services across the drug development and commercialization continuum. The company specializes in oral solid and non-sterile oral liquid dosage forms, particularly for pediatric, geriatric, and controlled substance applications.

1 investor

US-based AI-driven data intelligence platform for drug discovery and computational biology.

1 investor

Milestone Pharmaceuticals is a life sciences company that develops therapies for patients with cardiovascular and other diseases.

1 investor

Millennium Health is a healthcare company that provides drug testing and related clinical services. The company operates with a strong focus on compliance and ethical standards across its operations.

1 investor

Mimark is a biotechnology company developing diagnostic tools for gynecological diseases through biomarker research. The company aims to make testing less invasive and more precise for patients, clinicians, hospitals, and diagnostic manufacturers.

1 investor

1 investor

Mimetogen is a biotechnology company developing novel therapeutics, with a focus on tavilermide for ophthalmic indications including dry eye disease. The company brings together expertise in drug discovery, development, and clinical research to advance treatment options in ophthalmology.

1 investor

Mimio makes a daily supplement built from fasting metabolites that aims to recreate the cellular health and longevity benefits of prolonged fasting without requiring users to fast. The consumer product is positioned around autophagy support, healthy aging, appetite control, and metabolic health.

1 investor